Sickle Cell Disease
Showing 9976 - 10000 of >10,000
Follow-up of Nutritional Risk: DRECO Study
Recruiting
- Nutrition Disorders
- Malnutrition
-
A Coruña, Spain
- +24 more
Jun 22, 2022
Atherosclerotic Cardiovascular Disease Trial in Worldwide (Placebo, Olpasiran)
Recruiting
- Atherosclerotic Cardiovascular Disease
- Placebo
- Olpasiran
-
Huntsville, Alabama
- +83 more
Feb 1, 2023
Dry Eye Disease: A Cross-Sectional Survey of Real-World Dry Eye
Completed
- Dry Eye Disease
-
East Hanover, New JerseyNovartis
Aug 25, 2023
IBD Trial (standard hepatitis B vaccine, accelerated HBV Vaccine)
Not yet recruiting
- Inflammatory Bowel Diseases
- standard hepatitis B vaccine
- accelerated HBV Vaccine
- (no location specified)
Jul 27, 2023
Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Lymphoproliferative Disorder Trial in Houston (LMP specific T cells)
Completed
- Hodgkin Lymphoma
- +5 more
- LMP specific T cells
-
Houston, Texas
- +1 more
Feb 5, 2020
HER2-positive Recurrent/Metastatic Breast Cancer Trial (Inetetamab, pyrotinib, chemo)
Not yet recruiting
- HER2-positive Recurrent/Metastatic Breast Cancer
- Inetetamab, pyrotinib, chemotherapy
- (no location specified)
Nov 16, 2022
Lymphoma, Head Neck Cancer Trial in Gloucester (spectroscopic measurement, FNA biopsy, histopathology and cytology)
Not yet recruiting
- Lymphoma
- Head and Neck Cancer
- spectroscopic measurement
- +2 more
-
Gloucester, Gloucestershire, United KingdomGloucestershire Hospitals NHS Foundation Trust
May 26, 2022
Haplo-identical Transplantation, Transplantation Trial in Paris (Evaluate the evolution of the psychic state of the donors
Not yet recruiting
- Haplo-identical Transplantation
- Transplantation
- Evaluate the evolution of the psychic state of the donors (ascendants and descendants), by means of questionnaires, within the framework of haplo-identical allograft.
-
Paris, FranceService D'hématologie Clinique et thérapie cellulaire - Hôpital
Oct 17, 2023
Comparison of Two Different Periodontal Classification
Completed
- Periodontal Diseases
- Periodontal classification
-
Kütahya, TurkeyKütahya Health Sciences University Faculty of Dentistry, Departm
Nov 8, 2022
Irritable Bowel Syndrome Overlaping Celiac Disease
Enrolling by invitation
- Celiac Disease
- +2 more
-
Warszawa, Mazowieckie, PolandSzpital Bielański im. Jerzego Popiełuszki
Feb 13, 2023
Langerhans Cell Histiocytosis Trial in Beijing (Cytarabine)
Recruiting
- Langerhans Cell Histiocytosis
-
Beijing, ChinaPeking Union Medical College Hospital
Jun 7, 2021
Coronary Artery Disease Trial in China
Not yet recruiting
- Coronary Artery Disease
-
Cangzhou, Hebei, China
- +8 more
May 4, 2023
Preoperative Anaemia prevaLence In surgiCal patiEnts
Recruiting
- Anemia
- +5 more
-
Frankfurt am Main, Hesse, GermanyJohann Wolfgang Goethe University Hospital
Mar 28, 2022
Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)
Not yet recruiting
- Acute Myeloid Leukemia, in Relapse
- Acute Myeloid Leukemia Refractory
- (no location specified)
Nov 9, 2023
Lymphoma, B-Cell Trial in United States (Pralatrexate, Vitamin B12, Folic Acid)
Crohn Disease, Resection Margins, Recurrence Trial in Amiens (cellvizio)
Recruiting
- Crohn Disease
- +2 more
- cellvizio
-
Amiens, FranceCHU Amiens Picardie
Apr 11, 2023
Relapsed Small Cell Lung Cancer, Anlotinib Trial in Hangzhou (anlotinib HCl combined with irinotecan or docetaxel)
Recruiting
- Relapsed Small Cell Lung Cancer
- Anlotinib
- anlotinib hydrochloride combined with irinotecan or docetaxel
-
Hangzhou, Zhejiang, ChinaAffiliated Hangzhou Cancer Hospital, Zhejiang University School
Feb 14, 2021
Metastatic Renal Cell Carcinoma Trial in Italy (sorafenib)
Active, not recruiting
- Metastatic Renal Cell Carcinoma
-
Milan, Mi, Italy
- +13 more
Sep 16, 2021
Obesity, Healthy Trial in Rochester (Ileocolonic-release conjugated bile acid, Placebo)
Not yet recruiting
- Obesity
- Healthy
- Ileocolonic-release conjugated bile acid
- Placebo
-
Rochester, MinnesotaMayo Clinic in Rochester
May 31, 2022
Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma Trial in Houston (Bortezomib, Carboplatin, Etoposide)
Completed
- Recurrent Classic Hodgkin Lymphoma
- Refractory Classic Hodgkin Lymphoma
- Bortezomib
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Apr 9, 2020
B-cell Malignancy, Low-grade, Non-Hodgkin Lymphoma, Mantle Cell Lymphoma Trial in China (BGB-16673)
Recruiting
- B-cell Malignancy, Low-grade
- +4 more
-
Beijing, Beijing, China
- +8 more
Jul 20, 2022
Advanced NSCLC Trial in Shanghai (SHR-A1811)
Recruiting
- Advanced Non-small Cell Lung Cancer
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Jun 1, 2021
Physical Therapy Trial in Giresun (Balance, Trunk control, Gait)
Completed
- Physical Therapy
- Balance
- +4 more
-
Giresun, TurkeyGiresun University
Oct 11, 2022
COVID-19 Trial in Beijing (SARS-CoV-2 Inactivated Vaccine, The SARS-CoV-2 Inactivated Vaccine)
Recruiting
- COVID-19
- SARS-CoV-2 Inactivated Vaccine
- The SARS-CoV-2 Inactivated Vaccine
-
Beijing, ChinaBeijing Centers for Diseases Control and Prevention
Sep 22, 2021